Slideshow

The Impact of Psoriatic Arthritis on Cardiovascular Risk Factors

Which came first: the psoriatic arthritis or the cardiovascular risk factors?

Reference1. Gulati AM, Salvesen Ø, Thomsen RS, et al. Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Trøndelag Health Study (HUNT). RMD Open. 2018;4:e000630. doi:10.1136/rmdopen-2017-000630.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Related Content
Yasmin Rustomji, MD, a resident at Rush University Medical Center
December 4th 2024

Patient Education Materials for Rheumatology, Internal Medicine Don’t Meet Readability Standards

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
CAR-T Therapy Gets Fast Tracked for Relapsed/Refractory SLE
December 3rd 2024

CAR-T Therapy Gets Fast Tracked for Relapsed/Refractory SLE

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Laure Gossec, MD, PhD, Professor of Rheumatology, Pitié-Salpêtrière Hospital and Sorbonne University - Pierre et Marie Curie Campus, Paris, France.
Published: November 30th 2024 | Updated: November 30th 2024

Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA

Victoria Johnson
PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering
November 28th 2024

PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.